oral, first-in-class CHIT1/AMCase chitinase inh.

for sarcoidosis/lung fibrosis, Ph. Ib complete

from opt. of literature molecule

J. Med. Chem., Oct. 20, 2020

OncoArendi Therapeutics SA, Warsaw, PL

Structure of molecule OATD-01

OATD-01 (OncoArendi Therapeutics oral, first-in-class CHIT1/AMCase chitinase inhibitor clinical candidate)


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: